Francesco Patti

Célpontok

• AQP4 1
• CD20 1

A kitöltött címkéket a kutató adta meg; a többi a publikációkból jön (a munkák száma).

Most

Vizsgálatok, publikációk és pályázatok 2024. nov. óta.

• Publikáció

  How patients with neuromyelitis optica spectrum disease accumulate disability.

  Multiple sclerosis (Houndmills, Basingstoke, England), 2026. okt.

• Publikáció

  Cognitive resilience and improvements in health-related quality of life over 4 years in people with relapsing multiple sclerosis treated with cladribine tablets: Results from the CLARIFY-MS Extension study.

  Multiple sclerosis and related disorders, 2026. szept.

• Publikáció

  Multiple sclerosis outcomes after cancer diagnosis in people with recorded chemotherapy exposure: A real-world MSBase study.

  Multiple sclerosis (Houndmills, Basingstoke, England), 2026. aug.

• Publikáció

  Correction: Stability in Cognition and Employment in People with Relapsing Multiple Sclerosis Treated with Cladribine Tablets: Two‑year Phase IV CLARIFY‑MS Study.

  Neurology and therapy, 2026. aug.

• Publikáció

  Profiling the long-term risk of severe adverse events in a cohort of multiple sclerosis patients treated with different treatment sequences: Results from the Italian Multiple Sclerosis and Related Disorders Registry (I-MS&RD) (ProSA study).

  Multiple sclerosis (Houndmills, Basingstoke, England), 2026. júl.

• Publikáció

  A predictive tool for early treatment escalation after initiation of moderate-efficacy therapy in pediatric-onset multiple sclerosis.

  Multiple sclerosis (Houndmills, Basingstoke, England), 2026. jún.

• Publikáció

  Use of High-Efficacy Therapy in Children With Multiple Sclerosis to Prevent Long-Term Disability.

  Neurology, 2026. máj.

• Publikáció

  Threshold-Dependent Discordance Between STRATIFY JCV™ and IMMUNOWELL™ Assays in Relapsing Multiple Sclerosis.

  Neurology and therapy, 2026. ápr.

• Publikáció

  SPG4 and Dementia: Expanding the Clinical Spectrum.

  Annals of clinical and translational neurology, 2026. márc.

• Publikáció

  Comparative effectiveness of anti-CD20 therapies and S1P receptor modulators in late-onset multiple sclerosis: real-world evidence from the MSBase registry.

  Therapeutic advances in neurological disorders, 2026. márc.

• Publikáció

  Stability in Cognition and Employment in People with Relapsing Multiple Sclerosis Treated with Cladribine Tablets: Two-year Phase IV CLARIFY-MS Study.

  Neurology and therapy, 2026. márc.

• Publikáció

  Impact of Age at Onset on Relapse and Disability in AQP4-IgG Neuromyelitis Optica Spectrum Disorder.

  Neurology, 2026. márc.

• Publikáció

  Effectiveness of Rituximab in rElapsiNg Multiple SclErosis previously treated with hiGhly-Active Disease modifying thErapies (RENEGADE study).

  Journal of neurology, 2025. dec.

• Publikáció

  Real-world effectiveness of horizontal switching between disease-modifying therapies in multiple sclerosis: a retrospective analysis of the MSBase Registry.

  Therapeutic advances in neurological disorders, 2025. dec.

• Publikáció

  Managing reactivation of multiple sclerosis during treatment with natalizumab.

  Multiple sclerosis (Houndmills, Basingstoke, England), 2025. dec.

• Publikáció

  Disability Worsening Phenotypes in Multiple Sclerosis and Impact of Disease-Modifying Treatments.

  Neurology, 2025. nov.

• Publikáció

  Comparative evaluation of STRATIFY JCV™ and IMMUNOWELL™ assays for anti-JCV antibody detection in natalizumab-treated RRMS patients.

  Therapeutic advances in neurological disorders, 2025. nov.

Intézmények

• University of Catania

Társszerzők

Ki köt össze minket

Add meg egy másik kutató profiljának linkjét vagy azonosítóját: megmutatjuk, ki publikált mindkettőtökkel.